Publications by authors named "E Bertoldi"

Background: Refractory cardiogenic shock (CS) is associated with high mortality rates, and the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) as a therapeutic option has generated discussions. Therefore, its cost-effectiveness, especially in low- and middle-income countries like Brazil, remains uncertain.Objectives: To conduct a cost-utility analysis from the Brazilian Unified Health System perspective to assess the cost-effectiveness of VA-ECMO combined with standard care compared to standard care alone in adult refractory CS patients.

View Article and Find Full Text PDF

Study Objective: To evaluate the cost-effectiveness of EtCO monitoring during in-hospital cardiorespiratory arrest (CA) care outside the intensive care unit (ICU) and emergency room department.

Design: We performed a cost-effectiveness analysis based on a simple decision model cost analysis and reported the study using the CHEERS checklist. Model inputs were derived from a retrospective Brazilian cohort study, complemented by information obtained through a literature review.

View Article and Find Full Text PDF

The development of fully renewable and biodegradable composites for short-term applications was pursued by combining a compatibilized poly(lactic acid) (PLA)/poly(butylene succinate-co-adipate) (PBSA) (60:40 wt:wt) blend with coffee silver skin (CSS), an industrial byproduct from coffee processing. An epoxy-based reactive agent (Joncryl ADR-4468) was added as a compatibilizer. CSS was incorporated at 5, 10, and 20 wt% in the blend both in the as-received state and after a simple thermal treatment in boiling water, which was performed to mitigate the negative impact of this filler on the rheological and mechanical properties of the blend.

View Article and Find Full Text PDF

Importance: Readmissions after an index heart failure (HF) hospitalization are a major contemporary health care problem.

Objective: To evaluate the feasibility and efficacy of an intensive telemonitoring strategy in the vulnerable period after an HF hospitalization.

Design, Setting, And Participants: This randomized clinical trial was conducted in 30 HF clinics in Brazil.

View Article and Find Full Text PDF

Pancreatic ductal adenocarcinomas (PDAC) are the fourth leading cause of death due to neoplasms. In view of the urgent need of effective treatments for PDAC, photodynamic therapy (PDT) appears as a promising alternative. However, its efficacy against PDAC and the mechanisms involved in cell death induction remain unclear.

View Article and Find Full Text PDF